Bank of America
QNCX icon

Bank of America’s Quince Therapeutics QNCX Stock Holding History

Bank of America’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-550
Closed -$10.1M – 8558
2021
Q3 		$10.1M Buy
+550
New +$8.75M ﹤0.01% 2847

Other funds holding QNCX

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of America's QNCX Position: Q1 2026 in Review

Bank of America sold out of Quince Therapeutics (QNCX) in Q1 2026, closing a stake of 100 shares — an estimated $67.1K sold.

Bank of America first reported a position in QNCX in Q2 2019 and held it in 27 quarters. The position peaked at $4.55M in Q3 2021. 43 funds tracked by Wall St. Rank hold QNCX as of Q1 2026.

  • Bank of America reported no remaining Quince Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 100 Quince Therapeutics shares in Q1 2026, an estimated $67.1K.
  • Bank of America first reported a position in Quince Therapeutics in Q2 2019 and held it in 27 quarters.
  • Bank of America's Quince Therapeutics position peaked at $4.55M in Q3 2021.
  • 43 funds tracked by Wall St. Rank held Quince Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.